SEC Form 3 · accession 0001209191-18-061385
Synthorx, Inc. · THOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Leveque
Officer — Chief Medical Officer
Period of report
Dec 6, 2018
Accepted (ET)
Dec 6, 2018 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609727
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 259,365 | D |
Table II — derivative securities
No Table II lines on this filing.